Advertisement

Topics

Pfizer launches vaccine study in Group B Streptococcus

04:33 EDT 20 Jun 2017 | Pharmafile

A potentially pivotal Phase 1 study has been launched by Pfizer into the use of its investigational vaccine as a preventative treatment for Group B Streptococcus (GBS) infection.

read more

Original Article: Pfizer launches vaccine study in Group B Streptococcus

NEXT ARTICLE

More From BioPortfolio on "Pfizer launches vaccine study in Group B Streptococcus"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...